Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. π€π
May 22, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
Artificial intelligence approaches for anti-addiction drug discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ππ
May 22, 2025
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π
May 21, 2025
Identification of hub biomarkers in coronary artery disease patients using machine learning and bioinformatic analyses.
Machine learning reveals 11 hub biomarkers for coronary artery disease, highlighting ITM2B’s potential role in inflammation. π«π¬
May 19, 2025
Datavant Acquires Aetion to Enhance Real-World Evidence Capabilities
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€
May 16, 2025
Construction of Sonosensitizer-Drug Co-Assembly Based on Deep Learning Method.
Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. π‘π¬
May 16, 2025
Decoding Virulence and Resistance in Klebsiella pneumoniae: Pharmacological Insights, Immunological Dynamics, and in Silico Therapeutic Strategies.
Klebsiella pneumoniae’s rising virulence and antibiotic resistance pose significant health risks. π¦ π Explore novel therapeutic strategies!
May 13, 2025
South Korea Introduces Tariff Support for Medical Technology Sector
South Korea’s government supports medtech firms with a new tariff center to address trade challenges. π°π·π
May 9, 2025
New AI Method Enhances Understanding of Cellular Responses to Drug Treatments
New AI method improves insights into cellular responses to drug treatments. π§¬π Researchers aim to enhance medical research and therapies.
May 6, 2025
Increase in Healthcare AI Adoption Amid Ongoing Data and Integration Issues
Healthcare AI adoption is rising, with 70% of providers implementing technologies. However, data integration issues remain a challenge. ππ€
May 2, 2025